Multiple sclerosis (MS) specialty drug costs now account for more than two-thirds of MS patients' total cost of care, according to a new study presented at the Academy of Managed Care Pharmacy 2012 Educational Conference in Cincinnati, Ohio, in October.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

From the Academy of Managed Care Pharmacy 2012 Educational Conference: MS specialty drug treatment costs climb to two-thirds of total MS treatment cost

Newsletter